tuberculosis treatment includes broad-spectrum antibiotics such as rifampicin, streptomycin and fluoroquinolones, which are also used against other pathogenic bacteria. We developed Drug Resistance Associated Genes database (DRAGdb), a manually curated repository of mutational data of drug resistance associated genes (DRAGs) across ESKAPE (i.e. Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) pathogens, and other bacteria with a special focus on Mycobacterium tuberculosis (MTB). Analysis of mutations in drug-resistant genes listed in DRAGdb suggested both homoplasy and pleiotropy to be associated with resistance. Homoplasy was observed in six genes namely gidB, gyrA, gyrB, rpoB, rpsL and rrs. For these genes, drug resistance-associated mutations at codon level were conserved in MTB, ESKAPE and many other bacteria. Pleiotropy was exemplified by a single nucleotide mutation that was associated with resistance to amikacin, gentamycin, rifampicin and vancomycin in Staphylococcus aureus. DRAGdb data also revealed that mutations in some genes such as pncA, inhA, katG and embA,B,C were specific to Mycobacterium species. for inhA and pncA, the mutations in the promoter region along with those in coding regions were associated with resistance to isoniazid and pyrazinamide respectively. In summary, the DRAGdb database is a compilation of all the major MTB drug resistance genes across bacterial species, which allows identification of homoplasy and pleiotropy phenomena of DRAGs. There is a rise in the use of broad spectrum antibiotics such as rifamycins, aminoglycosides and fluoroquinolones against tuberculosis (TB), as well as common bacterial infections such as gastro-intestinal infections 1-3. The multi-and extensively drug-resistant (MDR and XDR) Mycobacterium tuberculosis (MTB) pose a global threat to public health as new resistance mechanisms are developing and making the treatment for patients prolonged and expensive. Drug resistance is not restricted to TB, but also observed in common bacterial infections such as pneumonia and foodborne infections 4,5. Genome-wide analysis of MDR and XDR MTB reveals that drug resistance arises due to mutations in the gene and/or the promoter region. Drug resistance associated mutations are linked to increasing drug efflux, modifications of the drugs or their targets 6-8. The accessibility to next-generation sequencing technologies and characterization of bacteria specific drug resistance allows the extensive study of other pathogenic bacteria as well 9-11. Antibiotic resistance mutations specific to pathogenic bacteria are available. The Infectious Diseases Society of America has grouped Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. as ESKAPE pathogens that are capable of 'escaping' the actions of antibiotics thereby developing antibiotic resistance 12. The ESKAPE pathogens are the leading cause of Hospi...